## Contact Preventive Therapy: Age-Based Risk Stratification **Key Point:** Young children (<5 years) exposed to smear-positive TB have the HIGHEST risk of developing severe TB disease, including TB meningitis and disseminated TB. They are the PRIORITY for immediate preventive therapy. ### Age-Based Risk of TB Disease Progression in Contacts | Age Group | Risk of TB Disease | Risk of Severe TB | Priority for IPT | | --- | --- | --- | --- | | **<2 years** | 40–50% | Very high (disseminated, meningitis) | **URGENT** | | **2–5 years** | 20–30% | High (disseminated, meningitis) | **URGENT** | | **5–15 years** | 5–10% | Moderate (pulmonary) | High | | **>15 years** | 5–10% | Low (pulmonary) | Standard | **High-Yield:** Children <5 years exposed to smear-positive TB have: - 40–50% risk of developing TB infection within 12 months - 10–15% risk of progressing to active TB disease - 5–10% risk of severe disseminated TB or TB meningitis (especially <2 years) ### Why the 2-Year-Old Is Highest Priority 1. **Immature immune system** — cell-mediated immunity still developing; cannot contain Mycobacterium tuberculosis effectively 2. **Highest risk of disseminated TB** — bacilli can spread hematogenously → TB meningitis, miliary TB, TB lymphadenitis 3. **Rapid progression** — from infection to disease in weeks–months (vs. years in older children/adults) 4. **Highest mortality if untreated** — TB meningitis mortality >50% without treatment **Clinical Pearl:** The 5-year-old and 8-year-old are also exposed and should receive IPT, but the 2-year-old requires the MOST urgent initiation because the risk-benefit ratio for preventive therapy is most favorable in this age group. **Mnemonic: YOUNG CHILD TB RISK = URGENT IPT** - **Y**oung age (<5 years) - **O**pen airways (easier bacillary spread) - **U**nderdeveloped immunity - **N**eed preventive therapy immediately - **G**rave complications (meningitis, disseminated) - **C**ontact with smear-positive source - **H**igh progression risk - **I**soniazid preventive therapy (6–9 months) - **L**ower mortality with early IPT - **D**isease prevention >95% effective ### Contact Investigation Protocol ```mermaid flowchart TD A[Smear-positive TB patient identified]:::outcome --> B[Identify all household contacts]:::action B --> C{Age of contact?}:::decision C -->|<5 years| D[Immediate evaluation + IPT]:::urgent C -->|5-15 years| E[Screening + IPT if exposed]:::action C -->|>15 years| F[Screening + IPT if symptomatic]:::action D --> G[Isoniazid 10 mg/kg/day for 6 months]:::action E --> H[Isoniazid 10 mg/kg/day for 6 months]:::action F --> I[Isoniazid 5 mg/kg/day for 6 months]:::action ``` **Tip:** In India's NTEP, all children <5 years exposed to smear-positive TB are offered IPT regardless of TST/IGRA status, because the risk of progression is so high and IPT efficacy is >95%. [cite:Park 26e Ch 7; NTEP Guidelines 2023]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.